Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.
Mã chứng khoánSMTI
Tên công tySanara Medtech Inc
Ngày IPOApr 07, 1994
Giám đốc điều hànhMr. Suresh V. (Sam) Muppalla
Số lượng nhân viên141
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhApr 07
Địa chỉ1200 Summit Avenue
Thành phốFORT WORTH
Sàn giao dịch chứng khoánNASDAQ Capital Market Consolidated
Quốc giaUnited States of America
Mã bưu điện76102
Điện thoại18175292300
Trang webhttps://sanaramedtech.com/
Mã chứng khoánSMTI
Ngày IPOApr 07, 1994
Giám đốc điều hànhMr. Suresh V. (Sam) Muppalla
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu